Emergent BioSolutions Inc.: Emergent BioSolutions to Release Third Quarter 2018 Financial Results and Conduct a Conference Call on November 1, 2018

Tickers: EBS
GAITHERSBURG, Md., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, November 1, 2018 at 5:00 pm (Eastern Time) to discuss the financial results for the third quarter of 2018, recent business developments, revenue guidance for the fourth quarter of 2018, and revenue and net income guidance for full year 2018.

This conference call can be accessed live by telephone or by webcast:

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Wal-Mart Stores, Inc.
Live Teleconference Information:
Dial in number: (855) 766-6521
International dial in: (262) 912-6157
Conference ID: 93346559

Live Webcast Information:
Visit https://edge.media-server.com/m6/p/u4z3sdn3 for the live webcast feed.

A replay of the call can be accessed on Emergent's website emergentbiosolutions.com under 'Investors.'

About Emergent BioSolutions
Emergent BioSolutions Inc. is a global life sciences company seeking to protect and enhance life by focusing on providing specialty products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. Through our work, we envision protecting and enhancing 50 million lives with our products by 2025. Additional information about the company may be found at www.emergentbiosolutions.com. Find us on LinkedIn and follow us on Twitter @emergentbiosolu and Instagram @life_at_emergent.

Investor Contact:Robert G. Burrows
Vice President, Investor Relations

Media Contact:Lynn Kieffer
Vice President, Corporate Communications

Emergent BioSolutions


Emergent BioSolutions Inc. published this content on 11 October 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 11 October 2018 10:41:10 UTC